The answer is a resounding, yes
Consider trying tirzepatide (Zepbound) Tirzepatide works a little differently because it targets both GLP-1 and GIP receptors
For healthcare systems and policymakers, the evidence supports cautious optimism tempered by realistic acknowledgment of current limitations and the need for comprehensive approaches that address pharmacological efficacy, access, sustainability, and equity concerns
Book yours now
Researchers compared tirzepatide to other diabetes medications, such as insulin and semaglutide
The shared side effect profile Metformin commonly causes diarrhea, nausea, flatulence, indigestion, vomiting, and abdominal discomfort